Using artificial intelligence to improve chemotherapy decisions for brain tumor patients

Artificial Intelligence-based decision support for chemotherapy-response assessment in Brain Tumors

NIH-funded research Wm S. Middleton Memorial Veterans Hosp · NIH-10862550

This study is testing a new AI system that helps doctors figure out which glioblastoma patients, especially veterans, might not benefit from standard chemotherapy, so they can find better treatment options and avoid unnecessary costs and procedures.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWm S. Middleton Memorial Veterans Hosp NIH-funded
Lab location1 site (Madison, United States)
Project IDNIH-10862550 on NIH RePORTER

What this research studies

This research focuses on developing an artificial intelligence system to assess how well patients with glioblastoma respond to chemotherapy. By analyzing patient data, the AI aims to identify those who are unlikely to benefit from standard chemotherapy treatments, allowing for more personalized and effective treatment options. The goal is to reduce unnecessary procedures and costs associated with ineffective therapies, particularly for veterans who may face unique challenges. The study will also explore how to differentiate between tumor recurrence and treatment effects using advanced imaging techniques.

Who could benefit from this research

Good fit: Ideal candidates for this research include veterans diagnosed with glioblastoma who are undergoing or considering chemotherapy.

Not a fit: Patients with brain tumors other than glioblastoma or those not receiving chemotherapy may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more tailored treatment plans for brain tumor patients, improving outcomes and reducing unnecessary procedures.

How similar studies have performed: Other research has shown promise in using AI for treatment decision-making in oncology, indicating potential success for this approach.

Where this research is happening

Madison, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.